We are live on
!
Find out more
PIP
Peachtree Investment Partners Portfolio holdings
AUM
$312M
1-Year Est. Return
27.01%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+27.01%
3 Year Est. Return
+92.23%
5 Year Est. Return
+139.64%
10 Year Est. Return
–
AUM
$267M
AUM Growth
+$1.02M
(+0.38%)
Cap. Flow
-$4.78M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
69.01%
Holding
122
New
9
Increased
34
Reduced
48
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.81M |
| 2 |
Palantir
PLTR
|
+$808K |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$764K |
| 4 |
NVIDIA
NVDA
|
+$514K |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
+$480K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.64M |
| 2 |
Microsoft
MSFT
|
+$1.52M |
| 3 |
Home Depot
HD
|
+$610K |
| 4 |
NVO
Novo Nordisk
NVO
|
+$572K |
| 5 |
Costco
COST
|
+$470K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.48% |
| 2 | Healthcare | 13.52% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 11.7% |
| 5 | Consumer Staples | 6.31% |
Similar funds
CFLC
PIC
WMIG
JIC
TL
IPW
MIM
RGC
Peachtree Investment Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Peachtree Investment Partners held 122 positions worth $267M, up 0.38% from $266M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Peachtree Investment Partners's Q4 2024 filing shows 9 new, 34 increased, 48 reduced and 8 closed positions. Its largest new stake was Palantir: 13,870 shares worth $1.05M. The largest sale was Eli Lilly, an estimated $1.64M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
- Peachtree Investment Partners's largest Q4 2024 buy was Palantir: 13,870 shares worth $1.05M.
- Peachtree Investment Partners added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $1.81M increase.
- Peachtree Investment Partners's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $1.64M.
- Peachtree Investment Partners fully exited Novo Nordisk in Q4 2024, selling an estimated $572K.
- Peachtree Investment Partners's ten largest holdings make up 69% of its $267M portfolio in Q4 2024.
- Peachtree Investment Partners opened 9 new positions and closed 8 in Q4 2024.
- Peachtree Investment Partners's portfolio value rose 0.38% quarter-over-quarter to $267M.
Based on Peachtree Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.